NA Lung Cancer Screening Software Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143151
- Pages: 225
-
Format:
Short Description
North America Lung Cancer Screening Software Market, By Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACS, Practice Management, and Audit Log Tracking), Mode of Delivery (Web Based Solutions, On-Premise Solutions, and Cloud Based Solutions), Type (Computer Assisted Screening and Traditional Screening), Application (Small Cell Lung Cancer and Non-Small Cell Lung Cancer), Platform (Standalone and Integrated), Purchase Mode (Individual and Institutional), End User (Hospitals, Oncology Centers, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender and Third Party Distributors), Countries (U.S, Canada, and Mexico) Industry Trends and Forecast to 2029
Market Definition
Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique of screening lung cancer. Rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. These software help to manage patients participation in lung screening programs and provide an efficient way for healthcare professionals to collect, curate, and transfer data to clinicians and patients. In addition, these software enable in identifying patients at risk and automates flow of data with integrated electronic health records.
Market Segmentation
North America lung cancer screening software market is divided into seven notable segments which are based on product, mode of delivery, type, application, platform, purchase mode, end user, and distribution channel.
On the basis of product, the market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACS, practice management, and audit log tracking
On the basis of mode of delivery, the market is segmented into cloud based solutions, on-premise solutions, and web based solutions
On the basis of type, the market is segmented into computer-assisted screening and traditional screening
On the basis of application, the market is segmented into Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
On the basis of platform, the market is segmented into standalone and integrated
On the basis of purchase mode, the market is segmented into individual and institutional
On the basis of end user, the market is segmented into hospitals, oncology centers, ambulatory surgical centers, and others
On the basis of distribution channel, the market is segmented into direct tender and third party distributors
Market Players
Some of the major players operating in the North America lung cancer screening software market are:
Koninklijke Philiphs N.V
Siemens Healthcare GmbH
Nuance Communication, Inc.
General Electric Company
Oncocyte Corporation
Aidence.com
AstraZeneca
Canon Medical Informatics, Inc.
Coreline Soft, Co., Ltd.
Eon
Epic Systems Corporation
F. Hoffmann-La Roche Ltd
FUJIFILM Holdings Corporation
Genesystem
HealthMyne
Lungview
MagView
Median Technologies
Medtronic
MeVis Medical Solutions AG
MyCareWare Inc.
Optellum Ltd
PenRad Technologies Inc.
REVEALDX
Thynk Health
Volpara Health Limited
TABLE OF CONTENTS
1 INTRODUCTION 61
1.1 OBJECTIVES OF THE STUDY 61
1.2 MARKET DEFINITION 61
1.3 OVERVIEW OF NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET 61
1.4 LIMITATION 63
1.5 MARKETS COVERED 64
2 MARKET SEGMENTATION 67
2.1 MARKETS COVERED 67
2.2 GEOGRAPHICAL SCOPE 68
2.3 YEARS CONSIDERED FOR THE STUDY 69
2.4 CURRENCY AND PRICING 69
2.5 DBMR TRIPOD DATA VALIDATION MODEL 70
2.6 MULTIVARIATE MODELLING 73
2.7 PRODUCT LIFELINE CURVE 73
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 74
2.9 DBMR MARKET POSITION GRID 75
2.10 VENDOR SHARE ANALYSIS 77
2.11 SECONDARY SOURCES 78
2.12 ASSUMPTIONS 78
3 EXECUTIVE SUMMARY 79
4 PREMIUM INSIGHTS 83
5 REGULATIONS & REIMBURSEMENT 84
6 MARKET OVERVIEW 85
6.1 DRIVERS 87
6.1.1 INCREASE IN PREVALENCE OF LUNG CANCER CASES NORTH AMERICALY 87
6.1.2 INCREASE IN AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS AND FREQUENT SCREENING 87
6.1.3 GOVERNMENT INITIATIVES WERE UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES 88
6.1.4 GROWING NUMBER OF SCREENING PROGRAMS ACROSS THE GLOBE 88
6.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE 89
6.2 RESTRAINTS 90
6.2.1 ISSUES RELATED TO THE AVAILABILITY OF SOFTWARE 90
6.2.2 SCARCITY OF TECHNICALLY KNOWLEDGEABLE PROFESSIONALS FOR CANCER DIAGNOSIS 90
6.2.3 LACK OF FUNDING AND OTHER RESOURCES FROM VARIOUS REGIONS FOR CANCER AND ASSOCIATED DISORDERS 90
6.3 OPPORTUNITIES 91
6.3.1 RISING COLLABORATIONS, MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS 91
6.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS 92
6.3.3 MULTIPLE BENEFITS ASSOCIATED WITH LUNG CANCER SCREENING SOFTWARE 92
6.4 CHALLENGES 93
6.4.1 HIGH COST OF SCREENING SOFTWARE AND RELATED SERVICES 93
6.4.2 INCREASING CHALLENGES RELATED TO THE DEVELOPMENT OF LUNG CANCER SCREENING SOFTWARE 93
6.4.3 INCREASING COMPETITION IN THE MARKET 94
7 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY 95
7.1 OVERVIEW 96
7.2 CLOUD BASED SOLUTIONS 97
7.3 ON-PREMISE SOLUTIONS 98
7.4 WEB BASED SOLUTIONS 98
8 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT 100
8.1 OVERVIEW 101
8.2 LUNG CANCER SCREENING RADIOLOGY SOLUTION 103
8.2.1 ON-PREMISE SOLUTIONS 103
8.2.2 WEB BASED SOLUTIONS 104
8.2.3 CLOUD BASED SOLUTIONS 104
8.3 LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE 104
8.3.1 CLOUD BASED SOLUTIONS 105
8.3.2 ON-PREMISE SOLUTIONS 105
8.3.3 WEB BASED SOLUTIONS 105
8.4 NODULE MANAGEMENT SOFTWARE 105
8.4.1 CLOUD BASED SOLUTIONS 106
8.4.2 ON-PREMISE SOLUTIONS 106
8.4.3 WEB BASED SOLUTIONS 106
8.5 DATA COLLECTION AND REPORTING 107
8.5.1 CLOUD BASED SOLUTIONS 108
8.5.2 WEB BASED SOLUTIONS 108
8.5.3 ON-PREMISE SOLUTIONS 108
8.6 PATIENT COORDINATION AND WORKFLOW 108
8.6.1 CLOUD BASED SOLUTIONS 109
8.6.2 ON-PREMISE SOLUTIONS 109
8.6.3 WEB BASED SOLUTIONS 109
8.7 LUNG NODULE COMPUTER AIDED DETECTION 109
8.7.1 ON-PREMISE SOLUTIONS 110
8.7.2 CLOUD BASED SOLUTIONS 110
8.7.3 WEB BASED SOLUTIONS 110
8.8 PATHOLOGY AND CANCER STAGING 111
8.8.1 CLOUD BASED SOLUTIONS 112
8.8.2 ON-PREMISE SOLUTIONS 112
8.8.3 WEB BASED SOLUTIONS 112
8.9 STATISTICAL AUDIT REPORTING 112
8.9.1 CLOUD BASED SOLUTIONS 113
8.9.2 ON-PREMISE SOLUTIONS 113
8.9.3 WEB BASED SOLUTIONS 113
8.10 SCREENING PACS 113
8.10.1 CLOUD BASED SOLUTIONS 114
8.10.2 ON-PREMISE SOLUTIONS 114
8.10.3 WEB BASED SOLUTIONS 114
8.11 PRACTICE MANAGEMENT 114
8.11.1 CLOUD BASED SOLUTIONS 115
8.11.2 ON-PREMISE SOLUTIONS 116
8.11.3 WEB BASED SOLUTIONS 116
8.12 AUDIT LOG TRACKING 116
8.12.1 CLOUD BASED SOLUTIONS 117
8.12.2 ON-PREMISE SOLUTIONS 117
8.12.3 WEB BASED SOLUTIONS 117
9 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE 118
9.1 OVERVIEW 119
9.2 COMPUTER-ASSISTED SCREENING 120
9.2.1 CLOUD BASED SOLUTIONS 121
9.2.2 ON-PREMISE SOLUTIONS 121
9.2.3 WEB BASED SOLUTIONS 121
9.3 TRADITIONAL SCREENING 121
9.3.1 CLOUD BASED SOLUTIONS 122
9.3.2 ON-PREMISE SOLUTIONS 122
9.3.3 WEB BASED SOLUTIONS 122
10 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION 123
10.1 OVERVIEW 124
10.2 NON-SMALL CELL LUNG CANCER (NSCLC) 125
10.2.1 CLOUD BASED SOLUTIONS 126
10.2.2 ON-PREMISE SOLUTIONS 126
10.2.3 WEB BASED SOLUTIONS 126
10.3 SMALL CELL LUNG CANCER (SCLC) 126
10.3.1 CLOUD BASED SOLUTIONS 127
10.3.2 ON-PREMISE SOLUTIONS 127
10.3.3 WEB BASED SOLUTIONS 127
11 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM 128
11.1 OVERVIEW 129
11.2 STANDALONE 130
11.2.1 CLOUD BASED SOLUTIONS 131
11.2.2 ON-PREMISE SOLUTIONS 131
11.2.3 WEB BASED SOLUTIONS 131
11.3 INTEGRATED 131
11.3.1 CLOUD BASED SOLUTIONS 132
11.3.2 ON-PREMISE SOLUTIONS 132
11.3.3 WEB BASED SOLUTIONS 132
12 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE 133
12.1 OVERVIEW 134
12.2 INSTITUTIONAL 135
12.3 INDIVIDUAL 136
13 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER 137
13.1 OVERVIEW 138
13.2 ONCOLOGY CENTERS 139
13.3 HOSPITALS 140
13.4 AMBULATORY SURGICAL CENTERS 140
13.5 OTHERS 141
14 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL 142
14.1 OVERVIEW 143
14.2 DIRECT TENDERS 144
14.3 THIRD PARTY DISTRIBUTOR 145
15 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION 146
15.1 NORTH AMERICA 147
15.1.1 U.S. 158
15.1.2 CANADA 165
15.1.3 MEXICO 172
16 NORTH AMERICA LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY LANDSCAPE 179
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 179
17 SWOT ANALYSIS 180
18 COMPANY PROFILE 181
18.1 KONINKLIJKE PHILIPS N.V 181
18.1.1 COMPANY SNAPSHOT 181
18.1.2 REVENUE ANALYSIS 181
18.1.3 COMPANY SHARE ANALYSIS 182
18.1.4 PRODUCT PORTFOLIO 182
18.1.5 RECENT DEVELOPMENTS 182
18.2 SIEMENS HEALTHCARE GMBH 184
18.2.1 COMPANY SNAPSHOT 184
18.2.2 REVENUE ANALYSIS 184
18.2.3 COMPANY SHARE ANALYSIS 185
18.2.4 PRODUCT PORTFOLIO 185
18.2.5 RECENT DEVELOPMENTS 185
18.3 NUANCE COMMUNICATIONS, INC. 187
18.3.1 COMPANY SNAPSHOT 187
18.3.2 REVENUE ANALYSIS 187
18.3.3 COMPANY SHARE ANALYSIS 188
18.3.4 PRODUCT PORTFOLIO 188
18.3.5 RECENT DEVELOPMENTS 188
18.4 GENRAL ELECTRIC (GE HEALTHCARE) 190
18.4.1 COMPANY SNAPSHOT 190
18.4.2 COMPANY SHARE ANALYSIS 190
18.4.3 PRODUCT PORTFOLIO 191
18.4.4 RECENT DEVELOPMENTS 191
18.5 ONCOCYTE CORPORATION 192
18.5.1 COMPANY SNAPSHOT 192
18.5.2 REVENUE ANALYSIS 192
18.5.3 COMPANY SHARE ANALYSIS 193
18.5.4 PRODUCT PORTFOLIO 193
18.5.5 RECENT DEVELOPMENT 193
18.6 AIDENCE.COM 194
18.6.1 COMPANY SNAPSHOT 194
18.6.3 PRODUCT PORTFOLIO 194
18.6.4 RECENT DEVELOPMENT 194
18.7 ASTRAZENECA 195
18.7.1 COMPANY SNAPSHOT 195
18.7.2 REVENUE ANALYSIS 195
18.7.3 PRODUCT PORTFOLIO 196
18.7.4 RECENT DEVELOPMENT 196
18.8 CANON MEDICAL INFORMATICS, INC. 197
18.8.1 COMPANY SNAPSHOT 197
18.8.2 PRODUCT PORTFOLIO 197
18.8.3 RECENT DEVELOPMENTS 197
18.9 CORELINE SOFT, CO., LTD. 198
18.9.1 COMPANY SNAPSHOT 198
18.9.2 PRODUCT PORTFOLIO 198
18.9.3 RECENT DEVELOPMENTS 198
18.10 EON 200
18.10.1 COMPANY SNAPSHOT 200
18.10.2 PRODUCT PORTFOLIO 200
18.10.3 RECENT DEVELOPMENT 200
18.11 EPIC SYSTEMS CORPORATION 201
18.11.1 COMPANY SNAPSHOT 201
18.11.2 PRODUCT PORTFOLIO 201
18.11.3 RECENT DEVELOPMENT 201
18.12 F. HOFFMANN-LA ROCHE LTD 202
18.12.1 COMPANY SNAPSHOT 202
18.12.2 REVENUE ANALYSIS 202
18.12.3 PRODUCT PORTFOLIO 203
18.12.4 RECENT DEVELOPMENTS 203
18.13 FUJIFILM HOLDINGS CORPORATION 204
18.13.1 COMPANY SNAPSHOT 204
18.13.2 REVENUE ANALYSIS 204
18.13.3 PRODUCT PORTFOLIO 205
18.13.4 RECENT DEVELOPMENTS 205
18.14 GENESYSTEM 206
18.14.1 COMPANY SNAPSHOT 206
18.14.2 PRODUCT PORTFOLIO 206
18.14.3 RECENT DEVELOPMENT 206
18.15 HEALTHMYNE 207
18.15.1 COMPANY SNAPSHOT 207
18.15.2 PRODUCT PORTFOLIO 207
18.15.3 RECENT DEVELOPMENTS 208
18.16 LUNGVIEW 209
18.16.1 COMPANY SNAPSHOT 209
18.16.2 PRODUCT PORTFOLIO 209
18.16.3 RECENT DEVELOPMENT 209
18.17 MAGVIEW 210
18.17.1 COMPANY SNAPSHOT 210
18.17.2 PRODUCT PORTFOLIO 210
18.17.3 RECENT DEVELOPMENT 210
18.18 MEDIAN TECHNOLOGIES 211
18.18.1 COMPANY SNAPSHOT 211
18.18.2 REVENUE ANALYSIS 211
18.18.3 PRODUCT PORTFOLIO 212
18.18.4 RECENT DEVELOPMENT 212
18.19 MEDTRONIC 213
18.19.1 COMPANY SNAPSHOT 213
18.19.2 REVENUE ANALYSIS 213
18.19.3 PRODUCT PORTFOLIO 214
18.19.4 RECENT DEVELOPMENTS 214
18.20 MEVIS MEDICAL SOLUTIONS AG 215
18.20.1 COMPANY SNAPSHOT 215
18.20.2 REVENUE ANALYSIS 215
18.20.3 PRODUCT PORTFOLIO 216
18.20.4 RECENT DEVELOPMENT 216
18.21 MYCAREWARE INC. 217
18.21.1 COMPANY SNAPSHOT 217
18.21.2 PRODUCT PORTFOLIO 217
18.21.3 RECENT DEVELOPMENT 217
18.22 OPTELLUM LTD 218
18.22.1 COMPANY SNAPSHOT 218
18.22.2 PRODUCT PORTFOLIO 218
18.22.3 RECENT DEVELOPMENTS 218
18.23 PENRAD TECHNOLOGIES INC. 220
18.23.1 COMPANY SNAPSHOT 220
18.23.2 PRODUCT PORTFOLIO 220
18.23.3 RECENT DEVELOPMENT 220
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
